Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management
BEIJING, Nov. 27, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced the initiation of GRADUAL-3, its third large-scale phase 3 clinical study of the glucagon-like peptide-1 receptor agonist (GLP-1...
Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in global health
SINGAPORE, Nov. 27, 2025 /PRNewswire/ -- Patronus Biotech today announced a grant from the Gates Foundation to accelerate the development of its novel malaria vaccine and adjuvant program to support affordable access and use in global health. The...
Mabwell Announces First-Patient Dosing for Novel CDH17-Targeting ADC 7MW4911
SHANGHAI, Nov. 25, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed in the Phase I/II clinical trial of its independently...
Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis
Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management Joint research to enhance dementia diagnosis using the brain neurodegeneration imaging software 'Neurophet AQUA' SEOUL, South Korea,...
EF English Proficiency Index 2025 launched: AI-Powered Insights Reveal Global Language Shifts in a Fragmented World
Skills gap widespread; gender gap narrowing; youth proficiency low ZURICH, Nov. 19, 2025 /PRNewswire/ -- EF (Education First), a global provider of culturally immersive education, released the 2025 edition of its EF English Proficiency Index (EF...
Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University
TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.73 billion (USD 11.6 million1) in four R&D projects for the development of diagnostics and a...
Tencent's CarbonX Program 2.0 Identifies 50 Global Finalists in Race to Scale Climate Solutions
SHENZHEN, China, Oct. 29, 2025 /PRNewswire/ -- Tencent (0700.HK) today announced the top 50 finalists, coming from 12 countries and regions around the world, for its CarbonX Program 2.0 (CarbonX 2.0), a landmark initiative to accelerate next...
Work Programs Commence to Unlock Tantalum as a High-Value By-Product Critical Metal Opportunity
Shaakichiuwaanaan rapidly evolving into an emerging critical minerals powerhouse, with workstreams now underway on caesium, tantalum, and gallium opportunities MONTREAL, June 25, 2025 /PRNewswire/ -- June 26, 2025 – Sydney, Australia Highlights...
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy (IgAN). Findings...
UBTS and Cuber AI Launch Exploratory Study into Next-Gen Agentic AI for Logistics Innovation
Joint initiative to evaluate Agentic AI-driven transformation of supply chain operations across ASEAN SINGAPORE, May 30, 2025 /PRNewswire/ -- UBTS Pte Ltd, a leading Singapore homegrown logistics player, has embarked on an exploratory partnership...